Total Payments
$3,678
2024 Payments
$1,090
Companies
17
Transactions
84
Medicare Patients
1,223
Medicare Billing
$206,226
Payment Breakdown by Category
Food & Beverage$2,562 (69.6%)
Travel$1,117 (30.4%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,562 | 82 | 69.6% |
| Travel and Lodging | $1,117 | 2 | 30.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Fresenius USA Marketing, Inc. | $1,532 | 3 | $0 (2019) |
| AstraZeneca Pharmaceuticals LP | $1,115 | 29 | $0 (2024) |
| Amgen Inc. | $189.71 | 14 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $132.78 | 6 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $125.42 | 5 | $0 (2024) |
| Lilly USA, LLC | $105.02 | 5 | $0 (2024) |
| CALLIDITAS THERAPEUTICS US INC. | $95.00 | 4 | $0 (2024) |
| Novo Nordisk Inc | $71.83 | 3 | $0 (2024) |
| Travere Therapeutics, Inc. | $64.61 | 3 | $0 (2023) |
| Ardelyx, Inc. | $45.76 | 2 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,090 | 45 | AstraZeneca Pharmaceuticals LP ($418.15) |
| 2023 | $702.25 | 23 | AstraZeneca Pharmaceuticals LP ($398.47) |
| 2022 | $213.88 | 9 | AstraZeneca Pharmaceuticals LP ($186.47) |
| 2021 | $28.04 | 2 | Vifor Pharma, Inc. ($28.04) |
| 2019 | $1,532 | 3 | Fresenius USA Marketing, Inc. ($1,532) |
| 2018 | $111.66 | 2 | AstraZeneca Pharmaceuticals LP ($111.66) |
All Payment Transactions
84 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | Amgen Inc. | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $20.43 | General |
| Category: Inflammation/Rare Disease | ||||||
| 12/19/2024 | Amgen Inc. | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $18.73 | General |
| Category: Inflammation/Rare Disease | ||||||
| 12/05/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $23.40 | General |
| Category: Diabetes | ||||||
| 12/04/2024 | Novartis Pharmaceuticals Corporation | — | Food and Beverage | In-kind items and services | $20.13 | General |
| 11/19/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $20.98 | General |
| Category: Diabetes | ||||||
| 11/15/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $15.76 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/07/2024 | Amgen Inc. | TAVNEOS (Drug) | Food and Beverage | In-kind items and services | $22.78 | General |
| Category: Inflammation | ||||||
| 11/01/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $25.48 | General |
| Category: Cardio-renal | ||||||
| 10/29/2024 | Amgen Inc. | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $17.16 | General |
| Category: Inflammation/Rare Disease | ||||||
| 10/16/2024 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $25.35 | General |
| Category: Diabetes | ||||||
| 10/15/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $36.22 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/14/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $19.33 | General |
| Category: DIABETES | ||||||
| 10/03/2024 | Novartis Pharmaceuticals Corporation | — | Food and Beverage | In-kind items and services | $25.86 | General |
| 10/02/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $14.86 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/20/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $21.82 | General |
| Category: Diabetes | ||||||
| 09/13/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $23.08 | General |
| Category: Diabetes | ||||||
| 09/11/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $24.90 | General |
| Category: Cardio-renal | ||||||
| 08/29/2024 | Amgen Inc. | TAVNEOS (Drug) | Food and Beverage | In-kind items and services | $16.86 | General |
| Category: Inflammation | ||||||
| 08/27/2024 | Amgen Inc. | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $17.90 | General |
| Category: Inflammation/Rare Disease | ||||||
| 08/21/2024 | Novartis Pharmaceuticals Corporation | — | Food and Beverage | In-kind items and services | $26.74 | General |
| 08/01/2024 | Amgen Inc. | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $6.52 | General |
| Category: Inflammation/Rare Disease | ||||||
| 07/30/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $23.26 | General |
| Category: Cardio-renal | ||||||
| 07/25/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $20.91 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 07/11/2024 | Amgen Inc. | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $6.19 | General |
| Category: Inflammation/Rare Disease | ||||||
| 07/02/2024 | CALLIDITAS THERAPEUTICS US INC. | TARPEYO (Drug) | Food and Beverage | In-kind items and services | $23.81 | General |
| Category: Nephrology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 12 | 501 | 868 | $167,851 | $82,344 |
| 2022 | 10 | 427 | 842 | $164,726 | $79,626 |
| 2021 | 7 | 235 | 341 | $74,709 | $37,056 |
| 2020 | 3 | 60 | 127 | $37,221 | $7,200 |
Total Patients
1,223
Total Services
2,178
Medicare Billing
$206,226
Procedure Codes
32
All Medicare Procedures & Services
32 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 145 | 234 | $31,590 | $19,988 | 63.3% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 76 | 93 | $31,992 | $12,318 | 38.5% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 44 | 119 | $21,539 | $10,814 | 50.2% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 60 | 152 | $19,152 | $9,141 | 47.7% |
| 90961 | Dialysis services, 2-3 physician visits per month (20 years or older) | Office | 2023 | 16 | 38 | $17,290 | $8,449 | 48.9% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 31 | 39 | $7,098 | $5,110 | 72.0% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 34 | 34 | $8,874 | $5,085 | 57.3% |
| 90935 | Hemodialysis procedure with physician evaluation | Facility | 2023 | 33 | 85 | $14,365 | $4,615 | 32.1% |
| 90962 | Dialysis services, 1 physician visit per month (20 years or older) | Office | 2023 | 13 | 24 | $8,160 | $3,688 | 45.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 24 | 24 | $4,992 | $2,014 | 40.3% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 11 | 11 | $2,574 | $1,090 | 42.3% |
| 81003 | Automated urinalysis test | Office | 2023 | 14 | 15 | $225.00 | $33.00 | 14.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 121 | 267 | $36,045 | $22,547 | 62.6% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 82 | 244 | $44,164 | $18,895 | 42.8% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 76 | 81 | $27,864 | $12,190 | 43.7% |
| 90961 | Dialysis services, 2-3 physician visits per month (20 years or older) | Office | 2022 | 14 | 34 | $15,470 | $7,616 | 49.2% |
| 90935 | Hemodialysis procedure with physician evaluation | Facility | 2022 | 32 | 99 | $16,731 | $5,539 | 33.1% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 28 | 32 | $5,824 | $3,920 | 67.3% |
| 90962 | Dialysis services, 1 physician visit per month (20 years or older) | Office | 2022 | 11 | 22 | $7,480 | $3,450 | 46.1% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 25 | 25 | $6,525 | $2,776 | 42.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 21 | 21 | $4,368 | $2,655 | 60.8% |
| 81003 | Automated urinalysis test | Office | 2022 | 17 | 17 | $255.00 | $37.82 | 14.8% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 38 | 101 | $18,281 | $7,903 | 43.2% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 47 | 50 | $17,242 | $7,579 | 44.0% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Office | 2021 | 44 | 44 | $11,484 | $7,133 | 62.1% |
About Dr. Peter Umukoro, M.D
Dr. Peter Umukoro, M.D is a Nephrology healthcare provider based in Danville, Indiana. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/27/2016. The National Provider Identifier (NPI) number assigned to this provider is 1679924013.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Peter Umukoro, M.D has received a total of $3,678 in payments from pharmaceutical and medical device companies, with $1,090 received in 2024. These payments were reported across 84 transactions from 17 companies. The most common payment nature is "Food and Beverage" ($2,562).
As a Medicare-enrolled provider, Umukoro has provided services to 1,223 Medicare beneficiaries, totaling 2,178 services with total Medicare billing of $206,226. Data is available for 4 years (2020–2023), covering 32 distinct procedure/service records.
Ad
Practice Information
- Specialty Nephrology
- Location Danville, IN
- Active Since 06/27/2016
- Last Updated 12/04/2024
- Taxonomy Code 207RN0300X
- Entity Type Individual
- NPI Number 1679924013
Products in Payments
- FARXIGA (Drug) $1,003
- JARDIANCE (Drug) $148.95
- Kerendia (Drug) $132.78
- KRYSTEXXA (Biological) $127.12
- BRILINTA (Drug) $111.66
- TARPEYO (Drug) $95.00
- Ozempic (Drug) $71.83
- TAVNEOS (Drug) $62.59
- IBSRELA (Drug) $45.76
- LUPKYNIS (Drug) $38.76
- Veltassa (Drug) $28.04
- JYNARQUE (Drug) $25.10
- ACCRUFER (Drug) $17.19
- FUROSCIX (Drug) $14.16
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Nephrology Doctors in Danville
Dr. Yao-Foli Sekyema, M.d, M.D
Nephrology — Payments: $7,614
Nephrology $7,614
Jason George
Nephrology — Payments: $7,175
Nephrology $7,175
Dr. Michael Fredericks, M.d, M.D
Nephrology — Payments: $7,101
Nephrology $7,101
Dr. Evan Norfolk, M.d, M.D
Nephrology — Payments: $6,548
Nephrology $6,548
Namrita Baveja, M.d, M.D
Nephrology — Payments: $3,777
Nephrology $3,777
Dr. Franklin Maddux, Md, MD
Nephrology — Payments: $3,273
Nephrology $3,273